ENDRA Life Sciences Inc
NDRA
View Detailed Chart
4.580USD
+1.120+32.37%
Close 03/26, 16:00（ET）Quotes delayed by 15 min
476.35Market Cap
0.00P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+32.37%
5 Days
+34.31%
1 Month
+20.21%
6 Months
-6.53%
Year to Date
+1.10%
1 Year
+6.51%
View Detailed Chart
TradingKey Stock Score of ENDRA Life Sciences Inc
Currency: USD Updated: 2026-03-25Key Insights
ENDRA Life Sciences Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 195 out of 391 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 30.00.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
ENDRA Life Sciences Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
ENDRA Life Sciences Inc Highlights
StrengthsRisks
ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology to assess tissue fat content and monitor tissue ablation during minimally invasive procedures, at the point of patient care. TAEUS is focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease and metabolic dysfunction-associated steatohepatitis, chronic liver conditions that affect over two billion people globally, and for which there are no practical diagnostic tools. TAEUS technology uses a pulsed energy source, specifically, radio frequency (RF), to transmit energy deep into tissue and generate ultrasonic waves based on the tissue composition (or tissue chemistry), differentiating lean and fatty tissues. These waves are then detected with ultrasound sensors at the skin surface and used to create high-contrast images using its proprietary algorithms.
Overvalued
The company’s latest PE is 0.00, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 199.62K shares, increasing 48.30% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 12.94K shares of this stock.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
30.000
Target Price
+762.07%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
ENDRA Life Sciences Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
ENDRA Life Sciences Inc Info
ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology to assess tissue fat content and monitor tissue ablation during minimally invasive procedures, at the point of patient care. TAEUS is focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease and metabolic dysfunction-associated steatohepatitis, chronic liver conditions that affect over two billion people globally, and for which there are no practical diagnostic tools. TAEUS technology uses a pulsed energy source, specifically, radio frequency (RF), to transmit energy deep into tissue and generate ultrasonic waves based on the tissue composition (or tissue chemistry), differentiating lean and fatty tissues. These waves are then detected with ultrasound sensors at the skin surface and used to create high-contrast images using its proprietary algorithms.
Ticker SymbolNDRA
CompanyENDRA Life Sciences Inc
CEOTokman (Alexander Y)
Websitehttps://www.endrainc.com/
Related Instruments
-0.68%
-0.88%
+1.69%
-1.35%
+2.19%
+2.89%
+0.72%
+1.38%
-2.13%
+2.21%
-1.38%
+3.26%
+1.89%
+3.52%
+1.15%
0.00%
+2.01%
+0.28%
+0.62%
+0.03%Popular Symbols
252.980
+1.340 (+0.53%)
171.340
-3.860 (-2.20%)
68762.260
-212.950 (-0.31%)
273.280
-27.770 (-9.22%)
2060.780
-1.610 (-0.08%)
372.260
-13.690 (-3.55%)
4408.690
+28.630 (+0.65%)
92.639
-0.683 (-0.73%)
1.154
+0.001 (+0.09%)
159.670
-0.117 (-0.07%)
